NEWS: H&K will advise drug companies in new joint deal

Hill and Knowlton Healthcare has teamed up with health policy body the Health Services Management Unit (HSMU) to advise drug companies how to deal with the new market-driven NHS.

Hill and Knowlton Healthcare has teamed up with health policy body the

Health Services Management Unit (HSMU) to advise drug companies how to

deal with the new market-driven NHS.



The joint venture with HSMU, run by former NHS chief executive Sir

Duncan Nichol, is the first of its kind in the UK. HSMU senior

consultant Jill Pooley will initially work three days a week at H&K

offering its clients access to key personnel in the NHS.



According to Nichol, the venture, set to launch in April, is designed to

‘bridge the gap’ between the pharmaceutical industry and NHS. He said

the NHS was traditionally ‘deeply suspicious’ of approaches from drug

companies which they see as contributing to rising healthcare spend.



According to H&K Healthcare managing director Noel Hall, pharmaceutical

companies are keen to change their image from mere suppliers of drugs to

providers of ‘healthcare solutions’ through disease management

programmes such as Glaxo Wellcome’s research into epilepsy, started two

years ago.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in